Skip Navigation LinksHome > January 1, 2014 - Volume 65 - Issue 1 > Incidence of Hepatocellular Carcinoma in HIV-Infected Patien...
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0b013e3182a685dc
Brief Report: Clinical Science

Incidence of Hepatocellular Carcinoma in HIV-Infected Patients With Cirrhosis: A Prospective Study

Montes Ramírez, María Luisa MD*; Miró, José M. MD; Quereda, Carmen MD; Jou, Antoni MD§; von Wichmann, Miguel Ángel MD; Berenguer, Juan MD; González-García, Juan J. MD*; Hernando, Asunción MD#; Ortega, Enrique MD**; Sanz, José MD††; Arribas, José R. MD*; GESIDA 3703.FIPSE 36466503–N5 NEAT Study Group

Collapse Box

Abstract

Abstract: This study assesses the incidence of hepatocellular carcinoma (HCC) in a prospective cohort of HIV-infected patients, the majority receiving antiretroviral therapy, with liver cirrhosis from different etiologies, enrolled between 2004 and 2005 with median follow-up of 5 years. We followed 371 patients, 25.6% with decompensated cirrhosis at baseline. The incidence rate of HCC was 6.72 per 1000 person-years [95% confidence interval (CI): 2.6 to 10.9]. There was a trend toward a higher cumulative probability of developing HCC at 6 years of follow-up (considering death and liver transplant as competing risks) in patients with decompensated versus compensated cirrhosis at baseline (6% vs. 2%, P < 0.06).

© 2014 by Lippincott Williams & Wilkins

Login

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.